MEDIA

Caregiver Profile

Caregiver Profile

Meet Dr. Elizabeth Blume

EDUCATION

Undergraduate Degree

  • Brown University , 1986 , Providence , RI

Medical School

  • Case Western Reserve University , 1991 , Cleveland , OH

Residency

  • Boston Children's Hospital , 1994 , Boston , MA

Fellowship

  • Boston Children's Hospital , 1997 , Boston , MA

CERTIFICATIONS

  • American Board of Pediatrics, Pediatric Cardiology

PUBLICATIONS

Publications powered by Harvard Catalyst Profiles

  1. Burnout, professional fulfillment, and post-traumatic stress among pediatric solid organ transplant teams. Pediatr Transplant. 2021 Apr 16; e14020. View abstract
  2. Palliative Care Referrals in Cardiac Disease. Pediatrics. 2021 Mar; 147(3). View abstract
  3. Parent and Physician Understanding of Prognosis in Hospitalized Children With Advanced Heart Disease. J Am Heart Assoc. 2021 Jan 19; 10(2):e018488. View abstract
  4. Variability in clinical decision-making for ventricular assist device implantation in pediatrics. Pediatr Transplant. 2020 12; 24(8):e13840. View abstract
  5. Fourth Annual Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs) Report. Ann Thorac Surg. 2020 12; 110(6):1819-1831. View abstract
  6. Comparison of tissue Doppler imaging and conventional echocardiography to discriminate rejection from non-rejection after pediatric heart transplantation. Pediatr Transplant. 2020 08; 24(5):e13738. View abstract
  7. The re-occurrence of cardiomyopathy in propionic acidemia after liver transplantation. JIMD Rep. 2020 Jul; 54(1):3-8. View abstract
  8. Extracorporeal Membrane Oxygenation Support After Heart Transplantation in Children-Outcomes of a Single Center Cohort. Pediatr Crit Care Med. 2020 04; 21(4):332-339. View abstract
  9. Three-Dimensional Speckle Tracking Echocardiography for Assessment of Left Ventricular Function and Myocardial Mechanics after Pediatric Heart Transplantation. J Heart Lung Transplant. 2020 Apr; 39(4S):S457. View abstract
  10. "How are You Doing?": Patient and Family Support Resources for Children on Ventricular Assist Device. J Heart Lung Transplant. 2020 Apr; 39(4S):S465. View abstract
  11. Obesity Leads to Increased Mortality in Pediatric Heart Transplant Recipients - A Pediatric Heart Transplant Society Study. J Heart Lung Transplant. 2020 Apr; 39(4S):S85-S86. View abstract
  12. Association of Clinical Rejection Versus Rejection on Protocol Biopsy With Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients. Transplantation. 2020 01; 104(1):e31-e37. View abstract
  13. Fears and Stressors of Trainees Starting Fellowship in Pediatric Cardiology. Pediatr Cardiol. 2020 Apr; 41(4):677-682. View abstract
  14. Medical and end-of-life decision making in adolescents' pre-heart transplant: A descriptive pilot study. Palliat Med. 2020 03; 34(3):272-280. View abstract
  15. Congenital Cardiothoracic Surgeons and Palliative Care: A National Survey Study. J Palliat Care. 2021 Jan; 36(1):17-21. View abstract
  16. Integration of Pediatric Palliative Care Into Cardiac Intensive Care: A Champion-Based Model. Pediatrics. 2019 08; 144(2). View abstract
  17. Phenotypic Manifestations of Arrhythmogenic Cardiomyopathy in Children and Adolescents. J Am Coll Cardiol. 2019 07 23; 74(3):346-358. View abstract
  18. Is Doppler echocardiography useful for estimating left ventricular filling pressures in pediatric heart transplant recipients? Pediatr Transplant. 2019 11; 23(7):e13543. View abstract
  19. Early outcomes for low-risk pediatric heart transplant recipients and steroid avoidance: A multicenter cohort study (Clinical Trials in Organ Transplantation in Children - CTOTC-04). J Heart Lung Transplant. 2019 09; 38(9):972-981. View abstract
  20. Palliative care and paediatric cardiology: current evidence and future directions. Lancet Child Adolesc Health. 2019 07; 3(7):502-510. View abstract
  21. Third Annual Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs) Report: Preimplant Characteristics and Outcomes. Ann Thorac Surg. 2019 04; 107(4):993-1004. View abstract
  22. Compassionate deactivation of ventricular assist devices in children: A survey of pediatric ventricular assist device clinicians' perspectives and practices. Pediatr Transplant. 2019 05; 23(3):e13359. View abstract
  23. When a Child Needs a Transplant but Lacks Familial Social Support. Pediatrics. 2019 01; 143(1). View abstract
  24. Ventricular Assist Device Support as a Bridge to Transplantation in Pediatric Patients. J Am Coll Cardiol. 2018 07 24; 72(4):402-415. View abstract
  25. Pediatric heart transplantation across a positive crossmatch: First year results from the CTOTC-04 multi-institutional study. Am J Transplant. 2018 09; 18(9):2148-2162. View abstract
  26. Incidence, characterization, and impact of newly detected donor-specific anti-HLA antibody in the first year after pediatric heart transplantation: A report from the CTOTC-04 study. Am J Transplant. 2018 09; 18(9):2163-2174. View abstract
  27. Study rationale, design, and pretransplantation alloantibody status: A first report of Clinical Trials in Organ Transplantation in Children-04 (CTOTC-04) in pediatric heart transplantation. Am J Transplant. 2018 09; 18(9):2135-2147. View abstract
  28. Physician Perspectives on Palliative Care for Children with Advanced Heart Disease: A Comparison between Pediatric Cardiology and Palliative Care Physicians. J Palliat Med. 2018 06; 21(6):773-779. View abstract
  29. Post-transplant outcomes in pediatric ventricular assist device patients: A PediMACS-Pediatric Heart Transplant Study linkage analysis. J Heart Lung Transplant. 2018 06; 37(6):715-722. View abstract
  30. Liver abnormalities and post-transplant survival in pediatric Fontan patients. Pediatr Transplant. 2017 Dec; 21(8). View abstract
  31. Homozygous EEF1A2 mutation causes dilated cardiomyopathy, failure to thrive, global developmental delay, epilepsy and early death. Hum Mol Genet. 2017 09 15; 26(18):3545-3552. View abstract
  32. Patterns and Outcomes of Care in Children With Advanced Heart Disease Receiving Palliative Care Consultation. J Pain Symptom Manage. 2018 02; 55(2):351-358. View abstract
  33. Eighth annual INTERMACS report: Special focus on framing the impact of adverse events. J Heart Lung Transplant. 2017 Oct; 36(10):1080-1086. View abstract
  34. Second annual Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs) report: Pre-implant characteristics and outcomes. J Heart Lung Transplant. 2018 01; 37(1):38-45. View abstract
  35. Pediatric Cardiology Provider Attitudes About Palliative Care: A Multicenter Survey Study. Pediatr Cardiol. 2017 Oct; 38(7):1324-1331. View abstract
  36. The Evolution of a Pediatric Ventricular Assist Device Program: The Boston Children's Hospital Experience. Pediatr Cardiol. 2017 Jun; 38(5):1032-1041. View abstract
  37. Deactivation of Ventricular Assist Devices: Perspectives and Experiences of Adult Cardiovascular Providers. J Card Fail. 2017 06; 23(6):485-486. View abstract
  38. Outcomes following implantation of mechanical circulatory support in adults with congenital heart disease: An analysis of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS). J Heart Lung Transplant. 2018 01; 37(1):89-99. View abstract
  39. Trans-Fontan baffle placement of an endocardial systemic ventricular pacing lead. HeartRhythm Case Rep. 2017 Feb; 3(2):129-132. View abstract
  40. Does Small Size Matter With Continuous Flow Devices?: Analysis of the INTERMACS Database of Adults With BSA =1.5 m2. JACC Heart Fail. 2017 02; 5(2):123-131. View abstract
  41. Vascular endothelial growth factor A is associated with the subsequent development of moderate or severe cardiac allograft vasculopathy in pediatric heart transplant recipients. J Heart Lung Transplant. 2017 Apr; 36(4):434-442. View abstract
  42. Palliative Care for Patients With End-Stage Cardiovascular Disease and Devices: A Report From the Palliative Care Working Group of the Geriatrics Section of the American College of Cardiology. JAMA Intern Med. 2016 07 01; 176(7):1017-9. View abstract
  43. Is Endomyocardial Biopsy a Safe and Useful Procedure in Children with Suspected Cardiomyopathy? Pediatr Cardiol. 2016 Oct; 37(7):1200-10. View abstract
  44. Report of the National Heart, Lung, and Blood Institute Working Group: An Integrated Network for Congenital Heart Disease Research. Circulation. 2016 Apr 05; 133(14):1410-8. View abstract
  45. Adverse events in children implanted with ventricular assist devices in the United States: Data from the Pediatric Interagency Registry for Mechanical Circulatory Support (PediMACS). J Heart Lung Transplant. 2016 05; 35(5):569-77. View abstract
  46. Outcomes of children implanted with ventricular assist devices in the United States: First analysis of the Pediatric Interagency Registry for Mechanical Circulatory Support (PediMACS). J Heart Lung Transplant. 2016 05; 35(5):578-84. View abstract
  47. Outcomes of pediatric patients supported with continuous-flow ventricular assist devices: A report from the Pediatric Interagency Registry for Mechanical Circulatory Support (PediMACS). J Heart Lung Transplant. 2016 05; 35(5):585-90. View abstract
  48. Is Myocarditis an Independent Risk Factor for Post-Transplant Mortality in Pediatric Heart Transplant Recipients? Circ Heart Fail. 2016 Jan; 9(1):e002328. View abstract
  49. Seventh INTERMACS annual report: 15,000 patients and counting. J Heart Lung Transplant. 2015 Dec; 34(12):1495-504. View abstract
  50. Pediatric mechanical circulatory support: available devices and outcomes as bridge-to-transplant therapy. Curr Opin Organ Transplant. 2015 Oct; 20(5):557-61. View abstract
  51. Physician and parent perceptions of prognosis and end-of-life experience in children with advanced heart disease. J Palliat Med. 2015 Apr; 18(4):318-23. View abstract
  52. Adrenergic receptor genotype influences heart failure severity and ß-blocker response in children with dilated cardiomyopathy. Pediatr Res. 2015 Feb; 77(2):363-9. View abstract
  53. Association of hemodynamic profiles with wait-list mortality in children listed for heart transplantation with idiopathic dilated cardiomyopathy. Am J Cardiol. 2015 Jan 15; 115(2):243-8. View abstract
  54. Treatment and outcomes of immune cytopenias following solid organ transplant in children. Pediatr Blood Cancer. 2015 02; 62(2):214-218. View abstract
  55. Parental perspectives on suffering and quality of life at end-of-life in children with advanced heart disease: an exploratory study*. Pediatr Crit Care Med. 2014 May; 15(4):336-42. View abstract
  56. Risk factors and outcome of Fontan-associated plastic bronchitis: a case-control study. J Am Heart Assoc. 2014 Apr 22; 3(2):e000865. View abstract
  57. Sixth INTERMACS annual report: a 10,000-patient database. J Heart Lung Transplant. 2014 Jun; 33(6):555-64. View abstract
  58. Ventricular assist devices in children: progress with an orphan device application. Circulation. 2014 Apr 08; 129(14):1530-7. View abstract
  59. Survival in patients removed from the heart transplant waiting list before receiving a transplant. J Heart Lung Transplant. 2014 Mar; 33(3):261-9. View abstract
  60. Tissue Doppler imaging for rejection surveillance in pediatric heart transplant recipients. J Heart Lung Transplant. 2013 Oct; 32(10):1027-33. View abstract
  61. Antibody depletion for the treatment of crossmatch-positive pediatric heart transplant recipients. Pediatr Transplant. 2013 Nov; 17(7):661-9. View abstract
  62. Prognostic value of exercise testing during heart transplant evaluation in children. Circ Heart Fail. 2013 Jul; 6(4):792-9. View abstract
  63. Ten yr of pediatric heart transplantation: a report from the Pediatric Heart Transplant Study. Pediatr Transplant. 2013 Mar; 17(2):99-111. View abstract
  64. Cardiovascular outcomes after the arterial switch operation for D-transposition of the great arteries. Circulation. 2013 Jan 22; 127(3):331-9. View abstract
  65. Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States. J Heart Lung Transplant. 2012 Dec; 31(12):1241-52. View abstract
  66. Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States. Circ Heart Fail. 2013 Jan; 6(1):e1-e11. View abstract
  67. Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States: executive summary. Ann Thorac Surg. 2012 Dec; 94(6):e163-8. View abstract
  68. Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States. Ann Thorac Surg. 2012 Dec; 94(6):2147-58. View abstract
  69. Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States: executive summary. Circ Heart Fail. 2013 Jan; 6(1):145-50. View abstract
  70. Cardiac allograft function during the first year after transplantation in rejection-free children and young adults. Circ Cardiovasc Imaging. 2012 Nov; 5(6):756-64. View abstract
  71. Allograft-Transmitted Histoplasma capsulatum Infection in a Solid Organ Transplant Recipient. J Pediatric Infect Dis Soc. 2013 Sep; 2(3):270-3. View abstract
  72. Patterns of care at end of life in children with advanced heart disease. Arch Pediatr Adolesc Med. 2012 Aug; 166(8):745-8. View abstract
  73. Utility of exercise stress echocardiography in pediatric cardiac transplant recipients: a single-center experience. J Heart Lung Transplant. 2012 May; 31(5):517-23. View abstract
  74. Endomyocardial biopsy and selective coronary angiography are low-risk procedures in pediatric heart transplant recipients: results of a multicenter experience. J Heart Lung Transplant. 2012 Apr; 31(4):398-409. View abstract
  75. Comparison of risk factors and outcomes for pediatric patients listed for heart transplantation after bidirectional Glenn and after Fontan: an analysis from the Pediatric Heart Transplant Study. J Heart Lung Transplant. 2012 Feb; 31(2):133-9. View abstract
  76. Sudden death after pediatric heart transplantation: analysis of data from the Pediatric Heart Transplant Study Group. J Heart Lung Transplant. 2011 Dec; 30(12):1395-402. View abstract
  77. Berlin Heart EXCOR Pediatric ventricular assist device Investigational Device Exemption study: study design and rationale. Am Heart J. 2011 Sep; 162(3):425-35.e6. View abstract
  78. Association of graft ischemic time with survival after heart transplant among children in the United States. J Heart Lung Transplant. 2011 Nov; 30(11):1244-9. View abstract
  79. Outcomes after listing for primary transplantation for infants with unoperated-on non-hypoplastic left heart syndrome congenital heart disease: a multi-institutional study. J Heart Lung Transplant. 2011 Sep; 30(9):1023-32. View abstract
  80. The impact of heart failure severity at time of listing for cardiac transplantation on survival in pediatric cardiomyopathy. J Heart Lung Transplant. 2011 Jul; 30(7):755-60. View abstract
  81. Changes in echocardiographic measures of systolic and diastolic function in children 1 year after hematopoietic SCT. Bone Marrow Transplant. 2011 Dec; 46(12):1532-9. View abstract
  82. Patterns of End-of-Life Care in Children with Advanced Heart Disease (747). J Pain Symptom Manage. 2011 Jan; 41(1):301. View abstract
  83. Infection and malignancy after pediatric heart transplantation: the role of induction therapy. J Heart Lung Transplant. 2011 Mar; 30(3):299-308. View abstract
  84. Rejection with hemodynamic compromise in the current era of pediatric heart transplantation: a multi-institutional study. J Heart Lung Transplant. 2011 Mar; 30(3):282-8. View abstract
  85. Minimizing infection and rejection death: clues acquired from 19 years of multi-institutional cardiac transplantation data. J Heart Lung Transplant. 2011 Feb; 30(2):151-7. View abstract
  86. Association of race and socioeconomic position with outcomes in pediatric heart transplant recipients. Am J Transplant. 2010 Sep; 10(9):2116-23. View abstract
  87. Outcomes of heart transplantation using donor hearts from infants with sudden infant death syndrome. J Heart Lung Transplant. 2010 Nov; 29(11):1226-30. View abstract
  88. BNP levels predict outcome in pediatric heart failure patients: post hoc analysis of the Pediatric Carvedilol Trial. Circ Heart Fail. 2010 Sep; 3(5):606-11. View abstract
  89. Impact of ABO-incompatible listing on wait-list outcomes among infants listed for heart transplantation in the United States: a propensity analysis. Circulation. 2010 May 04; 121(17):1926-33. View abstract
  90. Decline in rejection in the first year after pediatric cardiac transplantation: a multi-institutional study. J Heart Lung Transplant. 2010 Jun; 29(6):625-32. View abstract
  91. Use of a virtual community as a psychosocial support system in pediatric transplantation. Pediatr Transplant. 2010 Mar; 14(2):261-7. View abstract
  92. Safety and early outcomes using a corticosteroid-avoidance immunosuppression protocol in pediatric heart transplant recipients. J Heart Lung Transplant. 2010 May; 29(5):517-22. View abstract
  93. Racial and ethnic differences in mortality in children awaiting heart transplant in the United States. Am J Transplant. 2009 Dec; 9(12):2808-15. View abstract
  94. Incidence and risk factors for mortality in infants awaiting heart transplantation in the USA. J Heart Lung Transplant. 2009 Dec; 28(12):1292-8. View abstract
  95. Evaluating failing Fontans for heart transplantation: predictors of death. Ann Thorac Surg. 2009 Aug; 88(2):558-63; discussion 563-4. View abstract
  96. Socioeconomic position and graft failure in pediatric heart transplant recipients. Circ Heart Fail. 2009 May; 2(3):160-5. View abstract
  97. Waiting list mortality among children listed for heart transplantation in the United States. Circulation. 2009 Feb 10; 119(5):717-727. View abstract
  98. Predictors of death and transplant in patients with a mechanical circulatory support device: a multi-institutional study. J Heart Lung Transplant. 2009 Jan; 28(1):44-50. View abstract
  99. The longitudinal course of cardiomyopathy in Friedreich's ataxia during childhood. Pediatr Cardiol. 2009 Apr; 30(3):306-10. View abstract
  100. Ventricular assist devices as a bridge to heart transplantation in children. J Cardiovasc Nurs. 2008 Jan-Feb; 23(1):25-9. View abstract
  101. Intra-aortic balloon pump use in the failing Fontan circulation. Congenit Heart Dis. 2008 Jan-Feb; 3(1):60-2. View abstract
  102. Longitudinal changes in heart rate recovery after maximal exercise in pediatric heart transplant recipients: evidence of autonomic re-innervation? J Heart Lung Transplant. 2007 Dec; 26(12):1306-12. View abstract
  103. Carvedilol for children and adolescents with heart failure: a randomized controlled trial. JAMA. 2007 Sep 12; 298(10):1171-9. View abstract
  104. Outcome after Fontan failure and takedown to an intermediate palliative circulation. Ann Thorac Surg. 2007 Sep; 84(3):880-7. View abstract
  105. Parenting stress and parental post-traumatic stress disorder in families after pediatric heart transplantation. J Heart Lung Transplant. 2007 Feb; 26(2):120-6. View abstract
  106. Indications for heart transplantation in pediatric heart disease: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and Cardiovascular Surgery and Anesthesia; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007 Feb 06; 115(5):658-76. View abstract
  107. Successful use of bivalirudin for cardiac transplantation in a child with heparin-induced thrombocytopenia. J Heart Lung Transplant. 2006 Nov; 25(11):1376-9. View abstract
  108. Outcome of listing for cardiac transplantation for failed Fontan: a multi-institutional study. Circulation. 2006 Jul 25; 114(4):273-80. View abstract
  109. Successful implantation of a Berlin heart biventricular assist device in a failing single ventricle. J Thorac Cardiovasc Surg. 2006 Jun; 131(6):1407-8. View abstract
  110. Outcomes of children bridged to heart transplantation with ventricular assist devices: a multi-institutional study. Circulation. 2006 May 16; 113(19):2313-9. View abstract
  111. Prospective single-arm protocol of carvedilol in children with ventricular dysfunction. Pediatr Cardiol. 2006 May-Jun; 27(3):336-42. View abstract
  112. Lymphoproliferative disorders after paediatric heart transplantation: a multi-institutional study. Lancet. 2006 Jan 21; 367(9506):233-9. View abstract
  113. International Society for Heart and Lung Transplantation: Practice guidelines for management of heart failure in children. J Heart Lung Transplant. 2004 Dec; 23(12):1313-33. View abstract
  114. The longitudinal impact of psychological functioning, medical severity, and family functioning in pediatric heart transplantation. J Heart Lung Transplant. 2004 Apr; 23(4):473-80. View abstract
  115. Risk factors for recurrent rejection in pediatric heart transplantation: a multicenter experience. J Heart Lung Transplant. 2004 Feb; 23(2):178-85. View abstract
  116. Current status of heart transplantation in children: update 2003. Pediatr Clin North Am. 2003 Dec; 50(6):1375-91. View abstract
  117. Atrial tachyarrhythmias and permanent pacing after pediatric heart transplantation. J Heart Lung Transplant. 2003 Oct; 22(10):1126-33. View abstract
  118. Extracorporeal membrane oxygenation as a bridge to cardiac transplantation in a patient with cardiomyopathy and hemophilia A. Intensive Care Med. 2003 Jun; 29(6):985-988. View abstract
  119. Gastrointestinal complications after pediatric cardiac transplantation. J Heart Lung Transplant. 2002 Jul; 21(7):751-9. View abstract
  120. Arterial switch operation with a single coronary artery. J Thorac Cardiovasc Surg. 2002 Jun; 123(6):1164-72. View abstract
  121. Endothelial COX-2 induction by hypoxia liberates 6-keto-PGF1 alpha, a potent epithelial secretagogue. Adv Exp Med Biol. 2002; 507:107-12. View abstract
  122. Giant cell myocarditis in a 12-year-old girl with common variable immunodeficiency. Mayo Clin Proc. 2002 Jan; 77(1):92-6. View abstract
  123. Perioperative risk factors for development of protein-losing enteropathy following a Fontan procedure. Am J Cardiol. 2001 Nov 15; 88(10):1206-9. View abstract
  124. Carvedilol as therapy in pediatric heart failure: an initial multicenter experience. J Pediatr. 2001 Apr; 138(4):505-11. View abstract
  125. Clinical outcome of fenestrated Fontan patients after closure: the first 10 years. Circulation. 2000 Oct 24; 102(17):2094-9. View abstract
  126. Sialyl LewisX oligosaccharide preserves myocardial and endothelial function during cardioplegic ischemia. Ann Thorac Surg. 2000 Sep; 70(3):890-4. View abstract
  127. Long-term follow-up of pediatric cardiac patients requiring mechanical circulatory support. Ann Thorac Surg. 2000 Jan; 69(1):186-92. View abstract
  128. Left superior vena cava connection to unroofed coronary sinus associated with positional cyanosis: successful transcatheter treatment using Gianturco-Grifka vascular occlusion device. Catheter Cardiovasc Interv. 1999 Dec; 48(4):369-73. View abstract
  129. Sodium channel abnormalities are infrequent in patients with long QT syndrome: identification of two novel SCN5A mutations. Am J Med Genet. 1999 Oct 29; 86(5):470-6. View abstract
  130. Evolution of risk factors influencing early mortality of the arterial switch operation. J Am Coll Cardiol. 1999 May; 33(6):1702-9. View abstract
  131. Activated endothelial cells elicit paracrine induction of epithelial chloride secretion. 6-Keto-PGF1alpha is an epithelial secretagogue. J Clin Invest. 1998 Sep 15; 102(6):1161-72. View abstract
  132. Images in cardiovascular medicine. Anatomically corrected malposition of the great arteries [S,D,L]. Circulation. 1998 Mar 31; 97(12):1207. View abstract
  133. Long-term results of arterial switch repair of transposition of the great vessels. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 1998; 1:129-138. View abstract
  134. Soluble adhesion molecules in infants and children undergoing cardiopulmonary bypass. Circulation. 1997 Nov 04; 96(9 Suppl):II-352-7. View abstract
  135. A switch in time saves a statistical bind. JAMA. 1991 Dec 18; 266(23):3284-5. View abstract
  136. Amnesic patients give clues on structure of memory. JAMA. 1983 Oct 07; 250(13):1662-3. View abstract
  137. Palliation may block cure of incontinence in elderly. JAMA. 1983 Sep 16; 250(11):1371. View abstract
  138. Elderly patient needs assessment, not neglect. JAMA. 1983 Sep 02; 250(9):1132-3. View abstract
  139. Street drugs yield primate Parkinson's model. JAMA. 1983 Jul 01; 250(1):13-4. View abstract
  140. Premenstrual syndromes, depression linked. JAMA. 1983 Jun 03; 249(21):2864-6. View abstract
  141. Sound, shock waves shatter kidney stones. JAMA. 1983 May 13; 249(18):2434-5. View abstract
  142. Ambulatory dialysis: special boon for children. JAMA. 1983 May 06; 249(17):2290-1. View abstract
  143. 'Tricks' of trade aid kidney transplants. JAMA. 1983 May 06; 249(17):2288-90. View abstract
  144. Promising agents for limiting renal damage. JAMA. 1983 Apr 15; 249(15):1987. View abstract